Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BIOFLAVONOIDS Cause Osteoporosis? 88 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Osteoporosis have been filed in association with BIOFLAVONOIDS. This represents 40.2% of all adverse event reports for BIOFLAVONOIDS.

88
Reports of Osteoporosis with BIOFLAVONOIDS
40.2%
of all BIOFLAVONOIDS reports
88
Deaths
16
Hospitalizations

How Dangerous Is Osteoporosis From BIOFLAVONOIDS?

Of the 88 reports, 88 (100.0%) resulted in death, 16 (18.2%) required hospitalization, and 16 (18.2%) were considered life-threatening.

Is Osteoporosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BIOFLAVONOIDS. However, 88 reports have been filed with the FAERS database.

What Other Side Effects Does BIOFLAVONOIDS Cause?

Hypertension (121) Hypoaesthesia (121) Hypercholesterolaemia (119) Hypersensitivity (119) Impaired healing (116) Injury (109) Infection (108) Infusion related reaction (108) Joint dislocation (101) Irritable bowel syndrome (99)

What Other Drugs Cause Osteoporosis?

EMTRICITABINE\TENOFOVIR DISOPROXIL (7,436) TENOFOVIR DISOPROXIL (5,302) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,029) ADALIMUMAB (2,665) PREDNISONE (2,476) METHOTREXATE (2,018) ETANERCEPT (1,766) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,720) TOCILIZUMAB (1,689) ALENDRONATE (1,688)

Which BIOFLAVONOIDS Alternatives Have Lower Osteoporosis Risk?

BIOFLAVONOIDS vs BIOTIN BIOFLAVONOIDS vs BIPERIDEN BIOFLAVONOIDS vs BIRCH TRITERPENES BIOFLAVONOIDS vs BISACODYL BIOFLAVONOIDS vs BISACODYL OR DOCUSATE

Related Pages

BIOFLAVONOIDS Full Profile All Osteoporosis Reports All Drugs Causing Osteoporosis BIOFLAVONOIDS Demographics